JPWO2022181798A1 - - Google Patents

Info

Publication number
JPWO2022181798A1
JPWO2022181798A1 JP2022541701A JP2022541701A JPWO2022181798A1 JP WO2022181798 A1 JPWO2022181798 A1 JP WO2022181798A1 JP 2022541701 A JP2022541701 A JP 2022541701A JP 2022541701 A JP2022541701 A JP 2022541701A JP WO2022181798 A1 JPWO2022181798 A1 JP WO2022181798A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022541701A
Other languages
Japanese (ja)
Other versions
JPWO2022181798A5 (en
JP7313098B2 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022181798A1 publication Critical patent/JPWO2022181798A1/ja
Publication of JPWO2022181798A5 publication Critical patent/JPWO2022181798A5/ja
Application granted granted Critical
Publication of JP7313098B2 publication Critical patent/JP7313098B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2022541701A 2021-02-26 2022-02-25 How to adjust the growth factor mixture Active JP7313098B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021030807 2021-02-26
JP2021030807 2021-02-26
PCT/JP2022/008038 WO2022181798A1 (en) 2021-02-26 2022-02-25 Method for preparing growth factor mixture

Publications (3)

Publication Number Publication Date
JPWO2022181798A1 true JPWO2022181798A1 (en) 2022-09-01
JPWO2022181798A5 JPWO2022181798A5 (en) 2023-01-27
JP7313098B2 JP7313098B2 (en) 2023-07-24

Family

ID=83049240

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022541701A Active JP7313098B2 (en) 2021-02-26 2022-02-25 How to adjust the growth factor mixture

Country Status (2)

Country Link
JP (1) JP7313098B2 (en)
WO (1) WO2022181798A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150150942A1 (en) * 2007-10-15 2015-06-04 The Regents Of The University Of Colorado, A Body Corporate Methods for extracting platelets and compositions obtained therefrom
US20150224173A1 (en) * 2012-08-17 2015-08-13 Kasiak Research Pvt. Ltd. Method of preparing a growth factor concentrate derived from human platelets
JP2016529283A (en) * 2013-08-27 2016-09-23 クック・ジェネラル・バイオテクノロジー・エルエルシー Bioactive composition derivable from concentrated platelets and method for preparing and using the same
WO2019187200A1 (en) * 2018-03-30 2019-10-03 セルソース株式会社 Growth factor mixture and method for preparing same
WO2020166700A1 (en) * 2019-02-15 2020-08-20 テルモ株式会社 Platelet lysate production method, production system, and bag set
WO2021009660A1 (en) * 2019-07-12 2021-01-21 Vasanthi Palanivel Composition and methods for improving thickness and receptivity of endometrial lining

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150150942A1 (en) * 2007-10-15 2015-06-04 The Regents Of The University Of Colorado, A Body Corporate Methods for extracting platelets and compositions obtained therefrom
US20150224173A1 (en) * 2012-08-17 2015-08-13 Kasiak Research Pvt. Ltd. Method of preparing a growth factor concentrate derived from human platelets
JP2016529283A (en) * 2013-08-27 2016-09-23 クック・ジェネラル・バイオテクノロジー・エルエルシー Bioactive composition derivable from concentrated platelets and method for preparing and using the same
WO2019187200A1 (en) * 2018-03-30 2019-10-03 セルソース株式会社 Growth factor mixture and method for preparing same
WO2020166700A1 (en) * 2019-02-15 2020-08-20 テルモ株式会社 Platelet lysate production method, production system, and bag set
WO2021009660A1 (en) * 2019-07-12 2021-01-21 Vasanthi Palanivel Composition and methods for improving thickness and receptivity of endometrial lining

Also Published As

Publication number Publication date
JP7313098B2 (en) 2023-07-24
WO2022181798A1 (en) 2022-09-01

Similar Documents

Publication Publication Date Title
BR112021014123A2 (en)
BR112022024743A2 (en)
BR102021018859A2 (en)
BR102021015500A2 (en)
BR102021007058A2 (en)
BR102020022030A2 (en)
BR112023011610A2 (en)
BR112023011539A2 (en)
BR112023008976A2 (en)
BR112023009656A2 (en)
BR102021020147A2 (en)
BR102021018926A2 (en)
BR102021018167A2 (en)
BR102021017576A2 (en)
BR102021016837A2 (en)
BR102021016551A2 (en)
BR102021016375A2 (en)
BR102021016200A2 (en)
BR102021016176A2 (en)
BR102021015566A2 (en)
BR102021015450A8 (en)
BR102021015247A2 (en)
BR102021015220A2 (en)
BR102021014056A2 (en)
BR102021014044A2 (en)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220705

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220705

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20220705

AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20220719

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221011

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230203

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230301

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230420

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230616

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230705

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230704

R150 Certificate of patent or registration of utility model

Ref document number: 7313098

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150